Company
United StatesPublic company, NYSE: MCKMcKesson Corporation (NYSE: MCK), Everett, WA – FDA Inspections
Inspection records and compliance data for McKesson Corporation in Everett, Washington. 2 FDA inspections on record, last inspected September 11, 2017. Publicly traded as NYSE: MCK.
Company Profile
This profile covers McKesson Corporation based in Everett, Washington, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 1, 2012. Last inspected September 11, 2017.
Most cited issue areas
- Storage under appropriate conditions1 inspection
- Training--operations, GMPs, written procedures1 inspection
- Written calibration / inspection records not kept1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 11, 2017 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1029192 |
| October 1, 2012 | VAI | Foods & Cosmetics, Human Drugs · Drug Quality Assurance | 800605 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
McKesson Corporation
Stock ticker
MCK
Exchange
NYSE
Share price
$1,077.29
Market cap
$124.4B
Price as of
November 6, 2026
FEI Number
3019194
Address
710 132nd St SW, Everett, Washington 98204, United States
Country
United States
ID: 32c7a266-b737-4403-af3f-a88fccffeef3